Institutional investors purchased a net $6.5 million shares of MDCO during the quarter ended September 2013 and now own 100.76% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLINGTON MANAGEMENT CO. LLP Bought 2.9 Million shares of The Medicines Co
PARTNER FUND MANAGEMENT LP Bought 2.5 Million shares of The Medicines Co
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.1 Million shares of The Medicines Co